Effects “beyond-cholesterol” by statins: a 3-months therapy with simvastatin reduces the atherogenic lipoproteins in patients with premature coronary artery disease and in absence of the traditional cardiovascular risk factors.

Cecilia Camarda, Carlo Maria Barbagallo, Manfredi Rizzo, Salvatore Amato, Valentina Pernice

Risultato della ricerca: Articlepeer review

Lingua originaleUndefined/Unknown
pagine (da-a)157-162
RivistaTrends in Medicine
Volume4
Stato di pubblicazionePublished - 2004

Cita questo